Literature DB >> 11060067

Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.

R Mahieux1, P Horal, P Mauclère, O Mercereau-Puijalon, M Guillotte, L Meertens, E Murphy, A Gessain.   

Abstract

To gain insight on the significance of human T-cell lymphotropic virus type 1 (HTLV-1) indeterminate serological reactivities, we studied villagers of South Cameroon, focusing on a frequent and specific HTLV-1 Gag indeterminate profile (HGIP) pattern (gag p19, p26, p28, and p30 without p24 or Env gp21 and gp46). Among the 102 sera studied, 29 from all age groups had a stable HGIP pattern over a period of 4 years. There was no epidemiological evidence for sexual or vertical transmission of HGIP. Seventy-five percent of HGIP sera reacted positively on MT2 HTLV-1-infected cells by immunofluorescence assay. However, we could not isolate any HTLV-1 virus or detect the presence of p19 Gag protein in cultures of peripheral blood mononuclear cells obtained from individuals with strong HGIP reactivity. PCR experiments conducted with primers for HTLV-1 and HTLV-2 (HTLV-1/2 primers) encompassing different regions of the virus did not yield HTLV-1/2 proviral sequences from individuals with HGIP. Using 11 peptides corresponding to HTLV-1 or HTLV-2 immunodominant B epitopes in an enzyme-linked immunosorbent assay, one epitope corresponding to the Gag p19 carboxyl terminus was identified in 75% of HGIP sera, while it was recognized by only 41% of confirmed HTLV-1-positive sera. A positive correlation between HTLV-1 optical density values and titers of antibody to Plasmodium falciparum was also demonstrated. Finally, passage of sera through a P. falciparum-infected erythrocyte-coupled column was shown to specifically abrogate HGIP reactivity but not the HTLV-1 pattern, suggesting the existence of cross-reactivity between HTLV-1 Gag proteins and malaria-derived antigens. These data suggest that in Central Africa, this frequent and specific Western blot is not caused by HTLV-1 infection but could instead be associated with P. falciparum infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060067      PMCID: PMC87540     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  60 in total

1.  Human endogenous retroviruslike genome with type C pol sequences and gag sequences related to human T-cell lymphotropic viruses.

Authors:  D L Mager; J D Freeman
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Seroepidemiological survey of HTLV-I infection among randomized populations of western central African countries.

Authors:  E Delaporte; M Peeters; J P Durand; A Dupont; D Schrijvers; L Bedjabaga; C Honoré; S Ossari; A Trebucq; R Josse
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

3.  Epidemiology of HTLV-I in Gabon (Western Equatorial Africa).

Authors:  E Delaporte; A Dupont; M Peeters; R Josse; M Merlin; D Schrijvers; B Hamono; L Bedjabaga; H Cheringou; F Boyer
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

4.  Antibodies to HTLV-I in populations of the southwestern Pacific.

Authors:  D M Asher; J Goudsmit; K L Pomeroy; R M Garruto; M Bakker; S G Ono; N Elliot; K Harris; H Askins; Z Eldadah
Journal:  J Med Virol       Date:  1988-12       Impact factor: 2.327

5.  ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans.

Authors:  R J Biggar; P L Gigase; M Melbye; L Kestens; P S Sarin; A J Bodner; P Demedts; W J Stevens; L Paluku; C Delacollette
Journal:  Lancet       Date:  1985-09-07       Impact factor: 79.321

6.  Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.

Authors:  T J Palker; R M Scearce; W Ho; T D Copeland; S Oroszlan; M Popovic; B F Haynes
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

7.  Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.

Authors:  P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

8.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

9.  Type-I HTLV antibody in urban and rural Ghana, West Africa.

Authors:  R J Biggar; C Saxinger; C Gardiner; W E Collins; P H Levine; J W Clark; F K Nkrumah; W A Blattner
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396

10.  Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries.

Authors:  G de-Thé; A Gessain; L Gazzolo; M Robert-Guroff; G Najberg; A Calender; M Peti; G Brubaker; A Bensliman; F Fabry
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

View more
  29 in total

1.  A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.

Authors:  Claudia Filippone; Sylviane Bassot; Edouard Betsem; Patricia Tortevoye; Micheline Guillotte; Odile Mercereau-Puijalon; Sabine Plancoulaine; Sara Calattini; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Authors:  Madoka Kuramitsu; Tsuyoshi Sekizuka; Tadanori Yamochi; Sanaz Firouzi; Tomoo Sato; Kazumi Umeki; Daisuke Sasaki; Hiroo Hasegawa; Ryuji Kubota; Rieko Sobata; Chieko Matsumoto; Noriaki Kaneko; Haruka Momose; Kumiko Araki; Masumichi Saito; Kisato Nosaka; Atae Utsunomiya; Ki-Ryang Koh; Masao Ogata; Kaoru Uchimaru; Masako Iwanaga; Yasuko Sagara; Yoshihisa Yamano; Akihiko Okayama; Kiyonori Miura; Masahiro Satake; Shigeru Saito; Kazuo Itabashi; Kazunari Yamaguchi; Makoto Kuroda; Toshiki Watanabe; Kazu Okuma; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

3.  Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon.

Authors:  HaoQiang Zheng; Nathan D Wolfe; David M Sintasath; Ubald Tamoufe; Matthew Lebreton; Cyrille F Djoko; Joseph Le Doux Diffo; Brian L Pike; Walid Heneine; William M Switzer
Journal:  Virology       Date:  2010-03-30       Impact factor: 3.616

4.  Complete sequence of a novel highly divergent simian T-cell lymphotropic virus from wild-caught red-capped mangabeys (Cercocebus torquatus) from Cameroon: a new primate T-lymphotropic virus type 3 subtype.

Authors:  Laurent Meertens; Renaud Mahieux; Philippe Mauclère; John Lewis; Antoine Gessain
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test.

Authors:  Claude Tayou Tagny; Dora Mbanya; Edward L Murphy; Jean-Jacques Lefrère; Syria Laperche
Journal:  J Virol Methods       Date:  2014-01-30       Impact factor: 2.014

6.  Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.

Authors:  Saliou Diop; Sara Calattini; Julienne Abah-Dakou; Doudou Thiam; Lamine Diakhaté; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

7.  Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters.

Authors:  Nathan D Wolfe; Walid Heneine; Jean K Carr; Albert D Garcia; Vedapuri Shanmugam; Ubald Tamoufe; Judith N Torimiro; A Tassy Prosser; Matthew Lebreton; Eitel Mpoudi-Ngole; Francine E McCutchan; Deborah L Birx; Thomas M Folks; Donald S Burke; William M Switzer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

8.  Simian T-cell leukemia virus (STLV) infection in wild primate populations in Cameroon: evidence for dual STLV type 1 and type 3 infection in agile mangabeys (Cercocebus agilis).

Authors:  Valerie Courgnaud; Sonia Van Dooren; Florian Liegeois; Xavier Pourrut; Bernadette Abela; Severin Loul; Eitel Mpoudi-Ngole; Annemieke Vandamme; Eric Delaporte; Martine Peeters
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 9.  Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.

Authors:  E L Murphy
Journal:  Transfus Clin Biol       Date:  2016-01-05       Impact factor: 1.406

10.  Association of inconclusive sera for human immunodeficiency virus infection with malaria and Epstein-Barr virus infection in Central Africa.

Authors:  Francois-Xavier Mbopi-Keou; Angélique Ndjoyi-Mbiguino; Frédéric Talla; Hélène Péré; Khady Kebe; Mathieu Matta; Maurice Aurelien Sosso; Laurent Bélec
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.